m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs.
Psychedelic medicine (New Rochelle, N.Y.) March 1, 2026 Jonah Griffin-Stolbach, Hanna Molla, Donald Hedeker et al.
There has been great interest in the use of very low doses of psychedelic drugs like lysergic acid diethylamide (LSD) to improve mood and cognition. However, controlled studies have thus far provided little support for their efficacy. One challenge is that the subjective effects are subtle and on the threshold of detectability, whereas the questionnaires used to assess the drugs' effects were...